Small molecule hits shown to modulate c-Myc-IRES expression in a reporter construct in vitro were also tested ex vivo and shown to decrease c-Myc protein expression and modulate the viability of ovarian cancer cells (76). Here, MYC is linked to ovarian carcinoma.